Crestline Management’s Affimed AFMD Stock Holding History

Crestline Management’s Portfolio AFMD Stock Details AFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-33,417	Closed	-$618K	–	229
2018 Q1	$618K	Buy	+33,417	New	+$631K	0.08%	184

Other funds holding AFMD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Crestline Management's AFMD Position: Q2 2018 in Review

Crestline Management sold out of Affimed (AFMD) in Q2 2018, closing a stake of 33,417 shares — an estimated $618K sold.

Crestline Management first reported a position in AFMD in Q1 2018 and held it in 1 quarter. The position peaked at $618K in Q1 2018. 39 funds tracked by Wall St. Rank hold AFMD as of Q2 2018.

Crestline Management reported no remaining Affimed position as of Q2 2018 after selling out during the quarter.
Crestline Management sold 33,417 Affimed shares in Q2 2018, an estimated $618K.
Crestline Management first reported a position in Affimed in Q1 2018 and held it in 1 quarter.
Crestline Management's Affimed position peaked at $618K in Q1 2018.
39 funds tracked by Wall St. Rank held Affimed as of Q2 2018.

Based on Crestline Management's 13F filing for Q2 2018, filed 14 Aug 2018.